Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
Diffuse alveolar hemorrhage (DAH) is a life-threatening condition requiring prompt recognition. Conventional therapy, even when initiated early, may not have an immediate effect, and in severe cases, bleeding can persist despite treatment. We report the case of a previously healthy 33-year-old male...
Main Authors: | John Selickman, Jacob Fiocchi, Hem Desai, Kathryn M. Pendleton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007122001642 |
Similar Items
-
Use of Plasmapheresis and Immunosuppressants to Treat Diffuse Alveolar Hemorrhage in a Patient with Granulomatosis with Polyangiitis
by: Yasar Sattar, et al.
Published: (2019-07-01) -
A Distinctive Encounter With Diffuse Alveolar Hemorrhage in Granulomatosis With Polyangiitis and Pneumonia
by: Shrijan Shrestha, et al.
Published: (2025-01-01) -
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII
by: Zeynep İnce, et al.
Published: (2018-10-01) -
Massive Alveolar Hemorrhage During Wegener Granulomatosis: a Case Report
by: Gökhan Perincek, et al.
Published: (2011-11-01) -
Analysis of the effect of initial hemostasis resuscitation with recombinant human coagulation factor VII a on the treatment of postoperative hemorrhage in cardiac surgery
by: Yan Yu, et al.
Published: (2025-01-01)